Foster City, CA, United States of America

Jose Corvalan

USPTO Granted Patents = 34 


 

Average Co-Inventor Count = 5.9

ph-index = 20

Forward Citations = 1,104(Granted Patents)


Company Filing History:


Years Active: 2004-2018

Loading Chart...
Loading Chart...
Loading Chart...
34 patents (USPTO):Explore Patents

Title: Unveiling the Innovations of Inventor Jose Corvalan

Introduction:

Jose Corvalan, a prolific inventor based in Foster City, CA, has made significant contributions to the field of biotechnology with a total of 34 patents under his name. Known for his groundbreaking work in antibody research, Corvalan has brought forth novel solutions that have the potential to revolutionize diagnostic and therapeutic approaches.

Latest Patents:

1. Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof: Corvalan's invention focuses on novel antibodies targeting deletion mutants of epidermal growth factor receptors, particularly EGFRvIII. These human monoclonal antibodies have paved the way for advanced diagnostic and therapeutic formulations, offering new possibilities in cancer treatment.

2. Human monoclonal antibodies to CTLA-4: Corvalan's research has led to the development of fully human monoclonal antibodies against human cytotoxic T-lymphocyte antigen 4 (CTLA-4). By providing nucleotide and amino acid sequences, his work opens doors to the creation of antibodies with similar functionalities, holding promise for immune-related treatments.

Career Highlights:

Throughout his career, Jose Corvalan has left a lasting impact through his tenure at renowned biopharmaceutical companies. He has contributed his expertise to the research and development efforts of Amgen Fremont Inc. and Pfizer Corporation, two leading organizations in the healthcare industry. His innovative spirit and dedication have played a pivotal role in advancing the field of biotechnology.

Collaborations:

Corvalan's collaborative spirit is evident in his work alongside notable peers such as C. Geoffrey Davis and Xiao-Chi Jia. Together, they have synergized their talents and knowledge to drive forward groundbreaking research initiatives, fostering a culture of innovation and excellence.

Conclusion:

In conclusion, Jose Corvalan stands as a visionary inventor whose remarkable accomplishments in antibody research have positioned him as a trailblazer in the biotechnology landscape. His patented inventions not only showcase his scientific prowess but also hold the potential to transform the way we approach various health challenges. As he continues to push the boundaries of innovation, the legacy of Jose Corvalan undoubtedly shines bright in the realm of biopharmaceutical advancements.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…